Sergey O. Mazurenko

Sergey O. Mazurenko

Auto-generated profile, based on publicly available information

Sergey O. Mazurenko

Saint Petersburg State University

Research Focus & Metrics

Academic Career Length

36Years (1991-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 March 2011 in Proteomics
Verified
Journal Article
Closed access
PDF file
LALeonid Adonin
Leonid Adonin
AAAlexander Aseev
Alexander Aseev
VBVictor Bykov
Victor Bykov
AGAnatoly Grigoriev
Anatoly Grigoriev
VGVadim Govorun
Vadim Govorun
KSKonstantin Skryabin
Konstantin Skryabin

17 November 2018 in Meditsinskiy sovet = Medical Council
Verified
Journal Article
Open access
PDF file
AKA. E. Karateev
A. E. Karateev
ALA. M. Lila
A. M. Lila
IDI. S. Dydykina
I. S. Dydykina
PKP. R. Kamchatnov
P. R. Kamchatnov
SMS. O. Mazurenko
S. O. Mazurenko
MPM. V. Pchelintsev
M. V. Pchelintsev
The personalization of therapy is one of the innovative approaches gaining an increasingly strong foothold in modern medicine, implying an individual approach to each patient, taking into account the individual characteristics of the patient and the specific clinical case. This same standpoint of personified therapy should be used to plan rational analgesic therapy, the most important component of managing patients with the most common and socially significant diseases, with conditions that have a significant impact on the patient’s quality of life and worsen the course of concomitant diseases. The Meeting of Experts of different specialties such as rheumatologists, neurologists, cardiologists and clinical pharmacologists considered the key aspects of the prescription of NSAIDs, the most widely used class of painkillers, including those used for the relief of musculoskeletal pain. It was noted that when choosing NSAIDs, the practitioner should take into account the diagnosis, the planned duration of analgesic therapy, the intensity of pain, medical history data, the presence of comorbid diseases and risk factors for drug complications. There are different types of NSAIDs, some of which are most useful for urgent acute pain therapy (eg, ketoprofen), while others are most suitable for long-term pain management in chronic diseases (eg, etoricoxib). In any case, the practitioner should take into account the priority of patient safety and pay the utmost attention to the prevention of NSAIDassociated complications, and also keep in mind the duration of the specific drug administration permitted by the patient information leaflet. It was also noted that the launch of a new generic etoricoxib (Kostarox®) expands the possibilities of analgesic therapy for the Russian practitioners.

22 January 2022 in Atherothrombosis
Verified
Journal Article
Open access
PDF file
NSN. Y. Semigolovskii
N. Y. Semigolovskii
SMS. O. Mazurenko
S. O. Mazurenko
SSS. N. Semigolovskii
S. N. Semigolovskii
MSM. O. Shabalina
M. O. Shabalina
НСН. Ю. Семиголовский
Н. Ю. Семиголовский
As established today by a number of studies, transferred COVID-19 (even mild) is associated with a high risk of delayed heart damage. Although human coronaviruses are a minor cause of all cases of viral myocarditis, they have been associated with myocarditis in patients of all age groups. Post-COVID-19 myocarditis can be manifested by heart failure, heart rhythm and conduction disorders. A case report of 14-day hospitalization of an 89 y.o. man for a life-threatening myocardial conduction disorder – complete AV block – on the background of a permanent form of Arial fibrillation, accompanied by clinical death of the patient, coagulopathy, nosocomial pneumonia, heart failure and impaired consciousness. During the treatment, which included cardiopulmonary resuscitation, the use of temporary and then permanent pacemaker, antibiotics, levocarnitine, Fondaparinux, blood clot transfusions for profound thrombocytopenia, led to the restoration of heart rhythm and conduction, reduction of heart failure, cure of nosocomial pneumonia and restoration of exercise tolerance. Post- COVID-19 complications are currently still weakly understood and poorly predicted, but their treatment according to the general rules gives positive results. In patients with heparin-induced thrombocytopenia, as in patients with initial thrombocytopenia (including after COVID-19 conditions), it is advisable to use the drug Fondaparinux, which has proven itself in the prevention and treatment of arterial and venous thromboembolism. In the treatment of posthypoxic complications, it is appropriate to use Levocarnitine to correct post-ischemic changes in the myocardium and brain.

22 May 2017 in Biomedical Engineering
Verified
Journal Article
Closed access
PDF file
SMS. O. Mazurenko
S. O. Mazurenko
OMO. G. Mazurenko
O. G. Mazurenko
AEA. A. Enkin
A. A. Enkin
KSK. G. Staroselsky
K. G. Staroselsky

18 February 2022 in Nephrology (Saint-Petersburg)
Verified
Journal Article
Closed access
PDF file
SMS. O. Mazurenko
S. O. Mazurenko
ESE. V. Semenova
E. V. Semenova
OMO. G. Mazurenko
O. G. Mazurenko
YNY. A. Nakatis
Y. A. Nakatis
KGK. M. Grinev
K. M. Grinev
YGYulia Gomon
Yulia Gomon
BACKGROUND. Chronic kidney disease leads to a significant increase in the risk of fractures, which increases even more after kidney transplantation. THE AIM. The goal of this study was to develop simple, accessible criteria for predicting the risk of fracture in patients with a functioning kidney transplant. PATIENTS AND METHODS. The prospective study included 131 kidney transplant recipients (men-55, women-76) (average age 39.7±11.7 years). The duration of follow-up was 40.7±21.2 months. Bone mineral density was assessed using dual-energy x-ray absorptiometry. To determine the prognostic significance of variables, we used stepwise regression (Cox model) analysis. p < 0.05 was considered statistically significant. RESULTS. During the follow-up period, fractures were registered in 47 patients (35.9 %). Fractures were detected more often in women (42 %) than in men (27.3 %). All patients with fractures had lower bone mineral density and longer-term renal replacement therapy. Stepwise multivariate regression analysis showed that the combination of bone mineral density scores of lumbar vertebra and duration of renal replacement therapy best predicts the overall fracture risk. Adding the other variables to the analysis did not increase significantly their predictive value. A comparative analysis of the cumulative proportion of males and females with fractures confirmed a greater susceptibility of female transplant recipients to fractures. CONCLUSIONS. The combination of bone mineral density scores of the lumbar vertebra with the duration of renal replacement therapy best predict the risk of fracture in patients with kidney transplants and can be used in the choice of prevention measures.

2 December 2023 in Nephrology (Saint-Petersburg)
Verified
Journal Article
Closed access
PDF file
NKN. V. Khudyakova
N. V. Khudyakova
IPIvan Pchelin
Ivan Pchelin
ASA. N. Shishkin
A. N. Shishkin
SMS. O. Mazurenko
S. O. Mazurenko
VVV. A. Volovnikova
V. A. Volovnikova
VVVolha Vasilkova
Volha Vasilkova
Adrenoleukodystrophy (ALD) is the most common peroxisomal disease of X-linked recessive inheritance caused by a mutation in the ABCD 1 gene located on chromosome Xq28. A characteristic feature of ALD is the lack of correlation between genotype and phenotype. Depending on the time of onset, the main manifestations, and the rate of symptom progression, there are 6 main forms of the disease, but the most common is adrenomyeloneuropathy (AMN). When carefully examining patients with AMI, in most cases it is possible to identify urological pathology manifested by overactive bladder in both sexes and hypogonadism in men, which are hidden behind other numerous neurological symptoms and often remain undiagnosed. To date, there are few works devoted to the peculiarities of pathogenesis, clinical course, diagnosis and treatment of this pathology in ALD. In this article, we reviewed the current literature data on neurogenic bladder dysfunction and hypogonadism in ALD.